INS and obesity disorder: The present study findings are complementary to prior work, showing that FGF21 administration can improve glucose tolerance and insulin sensitivity in diabetic rodents [40,41,42,43] as well as a prior study showing that transgenic overexpression of FGF21 is protective against HFD-induced obesity in mice [3].